Antineoplastic/chemo for non-oncology indications

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org. 

2 posts / 0 new
Log in or register to post comments
Last post
Tue, 04/10/2018 - 13:43
#1
Tanya John
Tanya John's picture
Offline
Last seen: 3 months 1 week ago
Joined: 04/09/2018 - 10:55
Antineoplastic/chemo for non-oncology indications

Hello,
At out institution, we are revisiting this topic and updating our policies...

Would you mind sharing a policy/guideline related to:

1) Antineoplastic agents for non-oncology indications? (eg methotrexate, IV/PO cyclophosphamide)

2) Biologic agents given for non-oncology indications? (eg rituximab, infliximab)

3) Do you require informed consent for either 1 or 2? If so, do you require re-consenting each year?

Thank you,
Tanya

Tanya John, PharmD, CPPS
Medication Safety Coordinator
Department of Pharmacy
Massachusetts General Hospital
tjohn@partners.org

Top